Strategic objectives

In line with the Global Plan to Stop TB, the work of the New Diagnostics Working Group is guided by the following four strategic objectives.

Objective 1
Address existing knowledge gaps that obstruct the development of new diagnostic tools

Objective 2
Develop a portfolio of new diagnostic tests

Objective 3
Evaluate the portfolio of new diagnostic tools, demonstrate patient benefit and predict likely impact

Objective 4
Ensure that fully validated new diagnostic tools are widely available and appropriately used in endemic countries

Global TB Diagnostics Pipeline